Yilong Wang
Clinical trials sponsored by Yilong Wang, explained in plain language.
-
Brain injection bypasses barrier to treat severe stroke
Disease control Not yet recruitingThis early study tests if a new injection method can safely deliver a drug called RK-4 directly to the brain in people with severe stroke. The drug is given through a small hole in the skull, bypassing the blood-brain barrier. Only 6 people will take part, and the main goal is to…
Phase: NA • Sponsor: yilong Wang • Aim: Disease control
Last updated May 17, 2026 03:39 UTC
-
New drug ALT001 tested for rare brain disorder – safety first
Disease control Not yet recruitingThis early-stage study tests whether a new drug, ALT001, is safe for people with multiple system atrophy-cerebellar type (MSA-C), a rare brain disease that affects movement and balance. About 20 adults aged 30 to 75 with early-stage MSA-C will receive the drug and be closely moni…
Phase: EARLY_PHASE1 • Sponsor: yilong Wang • Aim: Disease control
Last updated May 15, 2026 11:55 UTC